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Natural killer cells as an initial defense against pathogens
Melissa B Lodoen and Lewis L LanierNatural killer (NK) cells serve as a crucial first line of defense
against tumors and a diverse range of pathogens. Recognition
of infection by NK cells is accomplished by the activation of
receptors on the NK cell surface, which initiate NK cell effector
functions. Many of the receptors and ligands involved in NK cell
antimicrobial activity have been identified, and we are
beginning to appreciate how they function during infection. In
addition, NK cells are activated by cytokines (e.g. interleukin 12
and type I interferons), which are products of activated
macrophages and dendritic cells. In response to these
activating stimuli, NK cells secrete cytokines and chemokines
and lyse target cells. Recent studies have focused on the
mechanisms by which NK cells recognize and respond to
viruses, parasites and bacteria, and on the unique role of NK
cells in innate immunity to infection.
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Introduction
Natural killer (NK) cells represent a distinct subset of
lymphoid cells that have innate immune functions [1].
Derived from the bone marrow, NK cells circulate in the
blood and become activated by cytokines or upon
encountering target cells that express ligands for NK cell
receptors [2]. NK cell receptors are encoded in the germ-
line and do not undergo somatic recombination like B-
and T-cell antigen receptors; it is the balance of signals
from activating and inhibitory receptors that determines
the outcome of NK cell activity. Some inhibitory recep-
tors recognize MHC class I, which is present on virtually
all healthy cells, and prevent NK cell attack against these
cells. Loss of MHC class I from cells owing to infection or
transformation can lead to NK cell activation, as proposed
by the ‘missing self hypothesis’ [3], provided that an
activating receptor is engaged. These activating NK
receptors bind to host-derived or pathogen-encodedwww.sciencedirect.comligands that are up-regulated on ‘stressed’ or infected
cells. Upon activation, NK cells directly lyse target cells
by exocytosis of perforin and granzymes and secrete
cytokines, such as interferon (IFN)-g and tumor necrosis
factor (TNF)-a, which mediate their immune response to
infection. In this manner, NK cells function as important
sentinels of the immune system, working as primary
responders and alerting the host to the presence of
infectious organisms.
In this review, we will highlight recent studies on the
mechanisms by which NK cells recognize and respond to
viruses, parasites and bacteria, and will underscore the
unique role of NK cells in innate immunity to infection
(Table 1).
Natural killer cells and viral infections
Natural killer cell–dendritic cell interactions and
Toll-like receptor 9
NK cells can respond to infection either directly or
indirectly. They respond directly by recognizing virus-
infected cells, and indirectly by interacting with dendritic
cells (DCs), which express Toll-like receptors (TLRs)
and secrete cytokines in response to encounter with
microbes.
Toll-like receptor 9 (TLR9) recognizes unmethylated
CpG DNA, a component of bacterial and viral DNA,
and signals for cellular activation through the adapter
protein MyD88. Several groups have recently examined
the role of TLR9 and MyD88 in response to mouse
cytomegalovirus (MCMV) infection by using MyD88-
deficient or TLR9-deficient mice. These immunodefi-
cient mice had elevated amounts of virus in their spleens
and livers compared with wild-type mice, which indicates
an increased susceptibility to infection and suggests a
crucial role for TLR9 and MyD88 in immunity to MCMV
[4,5,6,7]. Infection by MCMV activated IFN-produ-
cing cells and myeloid DCs, resulting in the production of
IFN-a and IL-12 through pathways dependent upon
MyD88 and TLR9 [5]. Mice that lacked MyD88 or
TLR9 had reduced amounts of IFN-a and IFN-b, inter-
leukin (IL)-12, macrophage inflammatory protein 1a
(MIP-1a) and IFN-g in their sera [4,5,6]. Of note,
NK cells from MCMV-infected TLR9- and MyD88-
deficient mice produced less IFN-g [4,5], had impaired
proliferation, and displayed reduced cytolytic activity
compared with NK cells from MCMV-infected wild-type
mice [5]. In addition, MCMV-infected CD11b+ DCs
directly activated NK cell IFN-g production by a
mechanism that required IFN-a and the NKG2D recep-
tor on NK cells [6].Current Opinion in Immunology 2006, 18:391–398
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Table 1
NK cells in immunity to pathogens.
Pathogen Mechanism of action References
Viruses MCMV TLR9 and MyD88 activation of DC-induced IFN-a and IL-12 production; this leads to
NK cell IFN-g production and cytotoxicity
[4,5,6,7]
Perforin and IFN-g generation by NK cells limits viral replication in the spleen and liver [8,9]
MCMV m157 binds Ly49H, induces NK cell IFN-g, MIP-1a, MIP-1b, RANTES and
ATAC, and controls MCMV in C57BL/6 mice
[17,18,19,20]
NK cells mediate resistance in NZW mice by multiple gene products [21]
NK cells protect MA/My mice from infection; Ly49P recognizes H-2Dk-restricted
ligand in MCMV-infected cells
[22,23]
KLRG1+ NK cells expand and contract in response to infection [26]
HCMV NK cell IFN-g, LTa/b and TNF induce IFN-b from infected cells and inhibit HCMV
replication
[10]
A truncated form of MICA escapes HCMV down-regulation and activates NK cell
NKG2D
[13]
CD94–NKG2C+ NK cells preferentially expand in response to infected fibroblasts [25]
Sendai virus Viral infection induces IFN-a and MICB gene transcription; this leads to NK cell
IFN-g production
[11]
Influenza A virus Viral infection induces IFN-a and MICB gene transcription; this leads to NK cell
IFN-g production
[11]
HIV Neonatal NK cells suppress replication of CCR5-trophic viruses [29]
NK cells from viremic patients produce more IFN-g and TNF-a than NK cells from
aviremic patients
[30]
MHV NK cell recruited to the CNS after intracerebral MHV infection enhance survival and
decrease viral titers
[33]
Ebola virus Injection of Ebola virus-like particles confers NK cell-mediated protection against
Ebola virus infection in mice
[34]
Parasites P. falciparum Human NK cells produce IFN-g in response to infected RBC [36,37,38,39]
NK cells form stable conjugates with infected RBC [39]
P. berghei ANKA Reduced pathogenesis in BALB/c mice maps to the NKC [40]
T. cruzi NK cells enhance survival of infected C57BL/6 mice and reduce parasitemia [42]
NK cells directly lyse parasites [41]
Bacteria Shigella flexneri NK cell IFN-g controls infection [43]
M. tuberculosis NK cells kill infected monocytes by a mechanism that involves NKp46 and NKG2D [44]
Figure 1
Interaction between DCs and NK cells during MCMV infection.
(a) MCMV infection activates DCs to produce IFN-a, IFN-b and
IL-12 by a MyD88- and TLR9-dependent pathway, as shown in
(b). IFN-a, IFN-b and IL-12 are potent activators of NK cell IFN-g
secretion and cytotoxic activity, which are crucial for NK cell
control of infection.Collectively, these data suggest that IFN-producing cells
and DCs are activated by MCMV through a TLR9- and
MyD88-dependent pathway to produce type I IFNs and
IL-12. These cytokines stimulate NK cell IFN-g produc-
tion and cytotoxic activity and ultimately control the viral
infection (Figure 1). In another report, it was found that
sera levels of IFN-a in TLR9-deficient mice were
unchanged compared with wild-type mice, indicating that
IFN-a production in response to MCMV infection is
independent of TLR9 [7]. Further studies will be
necessary to resolve these differences.
Natural killer cell antiviral effector mechanisms
NK cells use two main effector mechanisms to control
MCMV infection: the secretion of IFN-g and direct lysis
of infected cells by exocytosis of granules that contain
perforin and granzymes. Using mice deficient in perforin
or IFN-g and mice depleted of IFN-g by antibody, organ-
specific control of MCMV infection by NK cells was
observed: perforin mediated viral clearance in the spleen
and IFN-g mediated protection in the liver [8]. A recent
study re-evaluated the importance of these two effector
mechanisms during MCMV infection and found that
mice deficient in perforin or IFN-g had elevated viralCurrent Opinion in Immunology 2006, 18:391–398 www.sciencedirect.com
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compared with wild-type C57BL/6 mice [9]. By six days
post-infection, viral titers in the spleens and livers of
perforin-deficient mice remained higher than those of
wild-type mice, whereas viral titers in IFN-g-deficient
mice were higher only in the livers [9]. The authors noted
that the differences observed between their work and the
previous study might reflect the background of the mice
used in the experiments, because MCMV resistance
varies by mouse strain. The original study used per-
forin-deficient mice on a C57BL/6  129 mixed genetic
background, whereas the recent study used mice on a
C57BL/6 background. It is conceivable that NK cells in
different mouse strains use distinct antiviral effector
mechanisms in different organs.
Lymphotoxin (LT) and IFN-b have recently been impli-
cated in non-cytolytic NK cell control of human cytome-
galovirus (HCMV) infection. When cultured with
HCMV-infected fibroblasts, IL-2-activated NK cells pro-
duced IFN-g and induced IFN-b production by the
infected cells, which inhibited spread of the virus [10].
IFN-b induction appeared to involve NK cell secretion of
LTab and TNF, as soluble decoys of both of these
molecules prevented HCMV inhibition [10].
IFN-g production by NK cells might also contribute to
protection against influenza A and Sendai viruses. Con-
tact between human NK cells and virus-infected macro-
phages induced NK cell-mediated IFN-g production
[11]. In addition, gene transcription of IFN-g and major
histocompatibility complex class I-related chain B
(MICB), a ligand for the NKG2D receptor, by the NK
cells was enhanced by virus-induced IFN-a, which indi-
cates interplay among type I and type II IFNs during
influenza A and Sendai virus infections [11].
Human cytomegalovirus infection modulates natural
killer cell receptor function
Several studies have examined the effect of CMV infec-
tion on ligands for NK cell receptors [12]. Recent experi-
ments analyzing the NKG2D ligand MICA demonstrated
that HCMV infection down-regulated a full-length iso-
form of MICA from the surface of infected fibroblasts,
preventing lysis by the human NK cell line NKL [13].
However, a truncated form of MICA, which lacks a
cytoplasmic tail owing to a frameshift mutation, was
stably expressed on the surface of infected fibroblasts
and was efficiently lysed by NKL [13]. Interestingly, the
truncated allele was found to be the most common allele
in several human populations [14], which suggests that
polymorphism in the MICA gene might allow for
enhanced viral clearance through NKG2D-dependent
activation of NK cells. CD155, the ligand for the NK
cell activating receptors DNAM-1 (CD226) and TAC-
TILE (CD96), was targeted for down-regulation by the
HCMV glycoprotein UL141, rendering infected cellswww.sciencedirect.comresistant to NK cell lysis [15]. Down-regulation of
CD155 only occurred during infection of fibroblasts with
low-passage strains or clinical isolates of HCMV, and
UL141 functioned by preventing maturation of CD155
and retaining it in the endoplasmic reticulum [15].
An intriguing story has emerged regarding the ability of
the HCMV tegument protein pp65 to modulate NK cell
killing through the NKp30 receptor. Arnon et al. [16]
reported that pp65 binds to NKp30 and inhibits NKp30-
mediated NK cell lysis of HCMV-infected targets. Sur-
prisingly, pp65 appeared to cause dissociation of NKp30
from its signaling component, CD3z, thereby inhibiting
NKp30 activity [16]. The mechanism by which a virion
tegument protein, such as pp65, might access the inter-
action site between NKp30 and CD3z on the NK cell
plasma membrane remains unclear and will require
further investigation.
Natural killer cells mediate host resistance to murine
cytomegalovirus by diverse mechanisms
Resistance of C57BL/6 mice to MCMV infection is
mediated predominantly by the recognition of m157 —
a viral protein expressed on infected cells — by NK cell
activating receptor Ly49H [12]. Ligation of Ly49H by
m157 during MCMV infection results in the release of
cytokines and chemokines, including IFN-g, MIP-1a,
MIP-1b, RANTES and ATAC, which might play a role
in containing the infection [17]. A mutant virus that lacks
the m157 open reading frame displayed enhanced viru-
lence compared with wild-type MCMV in C57BL/6 mice,
which indicates that recognition of m157 by Ly49H
governs innate immune control of infection [18]. This
idea was reinforced by the emergence of viral escape
variants that have mutations in the m157 gene during
infection of C57BL/6 mice that lack adaptive immunity
[19,20]. In this manner, Ly49H+ NK cells might drive
the evolution of viruses that can escape from innate
immune control.
Like C57BL/6 mice, New Zealand White (NZW) mice
are resistant to MCMV infection by use of an NK cell-
dependent mechanism; depletion of NK cells with anti-
NK1.1 antibody resulted in elevated MCMV titers in the
spleen and liver [21]. However, resistance was indepen-
dent of Ly49H and m157, as NZW mice do not possess a
Ly49H gene. Moreover, treatment with an anti-Ly49H
antibody, which conferred MCMV susceptibility in
C57BL/6 mice, had no effect on viral titers in NZW mice
[21]. When MCMV-resistant NZW mice were mated and
backcrossed with other MCMV-sensitive mouse strains,
resistance was shown to be mediated by multiple gene
products [21], which remain to be identified.
NK cells also mediate immune protection against MCMV
in the MA/My mouse strain, which lacks the Ly49H
receptor. Genetic analysis has revealed that MA/MyCurrent Opinion in Immunology 2006, 18:391–398
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haplotype [22,23] and on a locus in the ‘NK gene
complex’, a region of mouse chromosome 6 that contains
a cluster of genes preferentially expressed by NK cells
[22]. Examination of the activating Ly49 receptors in the
MA/My strain identified Ly49P to be the only activating
Ly49 capable of responding to MCMV-infected cells
[22]. Although the ligand for Ly49P on MCMV-infected
cells has yet to be identified, it appears to be a ligand
associated with H-2Dk because antibody blockade of
either Ly49P or H-2Dk prevented Ly49P reporter cell
recognition of MCMV-infected cells [22].
The ability of wild mouse populations to control MCMV
infection was recently investigated. Viral replication in
the spleens and livers of wild outbred mice housed in a
specific pathogen-free facility was similar to growth of the
virus in ‘MCMV-susceptible’ BALB/c inbred mice [24].
Cytomegalovirus infection promotes the outgrowth of
specific natural killer cell populations
NK cells are a heterogeneous population composed of
cells that express overlapping subsets of activating and
inhibitory receptors. When human peripheral blood lym-
phocytes were cultured with HCMV-infected fibroblasts,
NK cells that express the activating CD94–NKG2C
receptor preferentially expanded. Expansion was contin-
gent on viral replication, on direct contact between lym-
phocytes and infected cells, and on signaling through the
CD94–NKG2C–DAP12 receptor complex [25]. Interest-
ingly, a MCMV viral mutant that lacked the US2-11
genes, and therefore could not down-regulate MHC class
I, did not drive expansion of this population [25]. Whether
the ligand for CD94–NKG2C (i.e. HLA-E) plays a role in
proliferation of CD94–NKG2C+ NK cells in response to
HCMV-infected fibroblasts awaits further investigation.
In the mouse, MCMV infection induces phenotypic
maturation of NK cells, including expression of killer
cell lectin-like receptor G1 (KLRG1) [26], which was
recently identified to be a receptor for E-cadherin [27,28].
Tracking of KLRG1+ cells indicated that NK cells acti-
vated by MCMV expanded in response to infection and
then contracted owing to cell death. A KLRG1 popula-
tion remained, which could respond to secondary infec-
tion [26]. Thus, CMV infection might shape the NK cell
repertoire, leading to the selective expansion of specific
NK cell subsets.
Human immunodeficiency virus infection and natural
killer cells
Neonatal NK cells might play a crucial role in protection
from perinatal human immunodeficiency virus (HIV)
infection. When cultured with autologous human HIV-
infected CD4+ T cells, neonatal NK cells suppressed HIV
replication to a greater degree than adult NK cells [29].
Suppression was dependent on a chemokine-mediatedCurrent Opinion in Immunology 2006, 18:391–398mechanism and on infection with a CCR5-dependent
virus, because NK cells could not suppress HIV replica-
tion by a CXCR4-dependent virus [29].
Highly active antiretroviral therapy can reduce HIV
replication and can result in a decrease in viral load in
the blood, known as viremia, of responsive patients.
Analysis of NK cells in chronically infected viremic
and aviremic HIV-1 patients found that the number of
CD3–CD56+ NK cells in the blood was dramatically
reduced in patients that had ongoing viral replication
compared with uninfected or aviremic patients [30].
However, a greater percentage of NK cells from viremic
patients, compared with aviremic patients, produced
IFN-g and TNF-a and expressed higher levels of
CD107a — a marker of granule exocytosis — after sti-
mulation with the tumor cell line K562 [30]. Thus, NK
cell activity is augmented in HIV-1 patients that have
ongoing viral replication in the blood, although total
numbers of NK cells are reduced.
It has long been appreciated that HIV infection down-
regulates expression of MHC class I. A recent study
revealed that certain strains of HIV selectively down-
regulated HLA-A2 and HLA-B7, but not HLA-C or
HLA-E, on infected cells [31]. HLA-C and HLA-E on
HIV-infected T cell blasts engaged inhibitory killer-cell
Ig-like receptors (KIRs) or CD94–NKG2A receptors,
respectively, on NK cells, inhibited killing of the virus-
infected cells [31], and blocked antibody-dependent cell-
mediated cytotoxicity against HIV-infected cells coated
with anti-gp120 [32]. The ability of certain HIV-1 strains
to selectively modulate MHC class I on infected cells
might determine whether or not NK cells can respond to
the infection.
Natural killer cell recruitment to the central nervous
system during viral infection
The chemokine CXCL10 might be crucial for innate
immunity to coronavirus because it recruits NK cells to
the central nervous system (CNS) during infection. Intra-
cerebral infection of RAG1/ mice with a CXCL10-
expressing mouse hepatitis virus (MHV) resulted in
the rapid infiltration of NK cells to the CNS, which
correlated with delayed mortality and reduced viral titers
compared with animals infected with wild-type virus [33].
Enhanced IFN-g secretion by NK cells was also observed
and was found to be essential for the antiviral effect,
possibly by limiting MHV replication [33].
Natural killer cell protection during Ebola virus
infection
The role of NK cells was examined in protection against
Ebola virus that was induced by treating mice with non-
replicating Ebola virus-like particles (VLPs) and then
challenging mice with a lethal dose of Ebola virus.
VLP immunization enhanced NK cell numbers in thewww.sciencedirect.com
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IFN-g and TNF-a, and induced cytotoxic activity [34].
Depletion of NK cells from mice prior to treatment with
VLPs resulted in decreased survival after infection with
Ebola virus compared with undepleted mice, and adop-
tive transfer of NK cells activated by VLPs into naı¨ve
mice enhanced their survival after Ebola infection,
further implicating NK cells in immunity to Ebola virus
[34]. Perforin, but not IFN-g, was shown to be required
for the protective effect. Although not addressed in this
report, the VLP-activated NK cells presumably augmen-
ted an adaptive immune response that was responsible for
protection against challenge with Ebola virus.
Natural killer cell activation during parasitic
infection
Natural killer cells respond to Plasmodium
falciparum
NK cells play an important role in the host response to
infection with Plasmodium falciparum — the causative
agent of malaria [35]. IFN-g production by human NK
cells cultured with red blood cells (RBCs) infected with P.
falciparum was dependent on IL-12 and IL-18 derived
from myeloid cells in the cultures [36]; the amount of
IFN-g generated by NK cells responding to infected
RBCs varied by donor [37,38]. It has been proposed
that the CD56bright subset of human NK cells is respon-
sible for cytokine production, whereas the CD56dim NK
cells are responsible for cytolytic activity. When stimu-
lated by malaria-infected erythrocytes, however, both NK
cell subsets produced abundant IFN-g [37]. Culture of
NK cells with RBC infected by several different strains of
P. falciparum also up-regulated CD69 and CD25 activa-
tion markers on NK cells from all donors.
The cellular and molecular requirements for NK cell
activation by malaria-infected RBCs have recently been
examined. Transwell assay experiments revealed that NK
cell IFN-g production required contact of human per-
ipheral blood mononuclear cells (PBMCs) with infected
RBCs, and that NK cells produced IFN-g only in the
presence of PBMCs [39]. NK cells formed stable con-
jugates with infected RBCs [39], and in some cases
reorganized the actin cytoskeleton after conjugate forma-
tion [37]. Purified NK cells, however, only produced
substantial amounts of IFN-g in the presence of mono-
cytes [38]. In addition, IL-18 production by macrophages
and MyD88 expression in both NK cells and macrophages
were required to induce IFN-g production by mouse NK
cells in response to infected RBCs [38]. Although NK
cells can interact with infected RBCs, robust NK cell
activation seems to require secretion of soluble mediators
by macrophages or monocytes. Specific NK receptors
involved in recognition of infected RBCs have not been
defined; however, in humans, KIR molecules might play a
role, because associations were found between the KIR
genotype and donor susceptibility to malaria [39].www.sciencedirect.comThe natural killer complex and Plasmodium berghei
pathogenesis
The NK complex (NKC; a region on mouse chromosome
6 containing several genes preferentially expressed by
NK cells) appears to contribute to pathogenesis of malaria
infection with Plasmodium berghei ANKA. C57BL/6 mice
succumb to severe infection with P. berghei ANKA,
whereas BALB/c mice are resistant. When BALB/c mice
congenic for the C57BL/6 NKC were infected with P.
berghei ANKA, parasitemia was unaffected but parasite-
specific antibody responses, pro-inflammatory gene
expression, and the TH1/TH2 balance were altered [40].
Natural killer cell activation by infection with
Trypanosoma cruzi
NK cells might also play a role in protection against
Trypanosoma cruzi infection. Depletion of NK cells from
mice using the anti-asialo GM1 antibody did not affect
survival when a low dose (1  104) of T. cruzi trypomas-
tigotes was used for infection [41]; however, when a
higher dose was used (5  105), NK-depleted mice had
compromised survival compared with C57BL/6 mice [42].
Interestingly, increased parasitemia was observed in NK-
depleted mice infected with the lower dose of T. cruzi,
possibly because NK cells could form intimate interac-
tions with trypomastigotes and contribute to their lysis
[41]. Lysis was independent of perforin but dependent
upon IL-12 [41], which suggests that monocytes or macro-
phages activated by T. cruzi might contribute to NK cell
activation by producing IL-12. NK cell cytotoxicity and
protection against T. cruzi infection was independent of
NK T cells [42].
Natural killer cells and bacterial infection
The importance of NK cells in protection against bacter-
ial infection has been controversial and might vary
depending upon the site of infection or type of inflam-
matory response elicited. Mice deficient in the RAG2 and
common g-chain genes (RAG/gc/) lack B, T and NK
cells and can be used to assess the contributions of these
cell types in the immune response. After infection with
Shigella flexneri, RAG/gc/ mice had severely compro-
mised survival compared with wild-type mice, possibly
owing to reduced production of IL-1, IL-6, TNF and IL-
12 [43]. Interestingly, RAG/ mice, which have NK cells,
had lower bacterial titers and increased survival compared
with RAG/gc/ mice, suggesting that NK cell produc-
tion of IFN-g alone might limit infection [43]. If this is
the case, it would be expected that depletion of NK cells
from RAG/ mice would lead to an exacerbated disease
phenotype.
One mechanism by which NK cells can modulate their
activity during infection is by altering receptor expres-
sion. Human NK cells cultured with Mycobacterium tuber-
culosis-infected monocytes up-regulated expression of the
activating receptors NKp30, NKp46 and NKG2D andCurrent Opinion in Immunology 2006, 18:391–398
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dependent mechanisms; this is known because antibodies
against these receptors inhibited cytotoxicity [44]. Infec-
tion of monocytes resulted in up-regulation of the
NKG2D ligand ULBP1 through TLR2 activation [44].
Thus, NKG2D and NKp46 might mediate the NK cell
response to M. tuberculosis infection. However, depletion
of NK cells in mice infected with M. tuberculosis did not
affect the bacterial load [45].
Although previously suggested to provide a protective
role in response to the intracellular bacterium Listeria
monocytogenes (LM), NK cells might not be involved in
bacterial clearance [46]. Recent work by Berg et al. [47]
has shown that when OT-1 TcR transgenic T cells were
transferred into IFN-g-deficient hosts prior to infection
with LM, these T cells secreted IFN-g and reduced the
bacterial burden, despite the fact that these T cells
recognized ovalbumin and not Listeria. This suggests a
bystander ‘innate’ role for the T cells [47]. In addition, the
transferred T cells localized with macrophages and LM
lesions in the spleen and liver. By contrast, when NK cells
were adoptively transferred into these recipients, the NK
cells localized to the splenic red pulp, away from infected
foci [47]. In this study, CD8+ T cells were shown to be the
more significant player in innate immunity to LM.
Interestingly, recent reports have revealed that type I
IFN hinders host control of LM, as mice deficient in this
signaling system had reduced bacterial burdens and
enhanced survival compared with wild-type mice [48–
50]. Because NK cells are activated by type I IFN, it
might be that NK cells worsen disease rather than protect
the host from LM infection. This is consistent with the
finding that mice that lack the DAP12 adapter protein,
which associates with several NK and myeloid cell acti-
vating receptors, exhibited enhanced TLR responses and
better control of bacterial infection [51].
Conclusions
Although originally identified by their ability to kill
tumors, emerging evidence strongly implicates NK cells
in host protection against microbial pathogens. In parti-
cular, a role for NK cells in host defense against CMV in
humans and mice is supported by the existence of viral
mutation in response to NK cell-mediated immunity and
the evolution of viral proteins that target the NKG2D
ligands in CMV-infected cells. Although less well-stu-
died, a developing theme is anti-parasitic and anti-bac-
terial immunity resulting from the interplay of NK cells
with DCs and macrophages. However, NK cells might not
always be beneficial in immune responses, as highlighted
by recent observations that NK cells might promote the
growth of rather than protect against LM. The future
promises a better molecular definition of the mechanisms
by which NK cells participate in innate immunity against
these pathogens.Current Opinion in Immunology 2006, 18:391–398Acknowledgements
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